AstraZeneca: to present new haematology data in San Diego

(CercleFinance.com) - AstraZeneca will present new clinical and real-life data in several haematology conditions at the 65th Annual Meeting of the American Society of Hematology (ASH) in San Diego, California, from 9 to 12 December.


A total of 63 abstracts will present 14 approved and potential new drugs in the company's portfolio and pipeline, including those from Alexion, AstraZeneca's rare disease division.

Anas Younes, Senior Vice President, Haematology R&D, AstraZeneca, said, “Our data at ASH will exemplify how we are advancing a range of innovative modalities including antibody drug conjugates, next-generation immunotherapies and T-cell engagers in haematology".

"We are proud to further our leadership in rare disease by sharing data from our robust haematology pipeline, reflecting our commitment to innovation and improving outcomes for the patients and families we serve," Gianluca Pirozzi, Senior Vice President, Head of Development, Regulatory and Safety, at Alexion.


Copyright (c) 2023 CercleFinance.com. All rights reserved.